tiprankstipranks
Trending News
More News >
StemCell Institute (JP:7096)
:7096
Japanese Market

StemCell Institute (7096) Ratios

Compare
0 Followers

StemCell Institute Ratios

JP:7096's free cash flow for Q3 2024 was ¥0.63. For the 2024 fiscal year, JP:7096's free cash flow was decreased by ¥ and operating cash flow was ¥0.15. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.20 1.20 1.32 1.37 1.22
Quick Ratio
1.19 1.19 1.31 1.36 1.20
Cash Ratio
0.74 0.76 0.97 1.15 1.06
Solvency Ratio
0.11 0.11 0.09 0.07 0.04
Operating Cash Flow Ratio
0.11 0.09 0.03 0.15 0.09
Short-Term Operating Cash Flow Coverage
6.96 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 664.58M¥ 664.58M¥ 1.03B¥ 1.07B¥ 514.03M
Leverage Ratios
Debt-to-Assets Ratio
0.07 <0.01 <0.01 0.00 0.00
Debt-to-Equity Ratio
0.20 <0.01 <0.01 0.00 0.00
Debt-to-Capital Ratio
0.16 <0.01 <0.01 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.14 0.00 0.00 0.00 0.00
Financial Leverage Ratio
2.85 2.43 2.53 2.48 2.99
Debt Service Coverage Ratio
7.53 0.00 0.00 8.54K 0.00
Interest Coverage Ratio
348.18 0.00 0.00 8.41K 0.00
Debt to Market Cap
0.04 0.00 0.00 0.00 0.00
Interest Debt Per Share
50.79 0.86 0.57 <0.01 0.00
Net Debt to EBITDA
-5.31 -5.31 -8.64 -11.35 -22.93
Profitability Margins
Gross Profit Margin
63.16%63.51%63.88%62.36%65.57%
EBIT Margin
21.16%16.68%14.23%11.93%6.16%
EBITDA Margin
25.95%21.52%18.36%17.37%8.49%
Operating Profit Margin
15.62%16.68%14.23%12.74%6.16%
Pretax Profit Margin
21.12%17.79%13.34%11.93%6.49%
Net Profit Margin
14.40%12.53%9.47%7.50%4.42%
Continuous Operations Profit Margin
14.40%12.53%9.47%7.50%4.43%
Net Income Per EBT
68.20%70.46%70.99%62.91%68.21%
EBT Per EBIT
135.17%106.66%93.75%93.66%105.26%
Return on Assets (ROA)
4.75%4.75%3.41%2.56%1.58%
Return on Equity (ROE)
11.55%11.55%8.62%6.36%4.72%
Return on Capital Employed (ROCE)
14.87%14.87%12.50%10.49%6.34%
Return on Invested Capital (ROIC)
10.47%10.47%8.87%6.60%4.33%
Return on Tangible Assets
4.78%4.78%3.42%2.58%1.58%
Earnings Yield
1.61%1.61%0.77%0.66%0.31%
Efficiency Ratios
Receivables Turnover
1.46 1.57 1.84 0.00 4.09
Payables Turnover
39.60 25.65 25.03 22.39 23.11
Inventory Turnover
19.36 21.42 19.20 16.70 15.11
Fixed Asset Turnover
2.32 3.73 3.23 2.75 2.44
Asset Turnover
0.36 0.38 0.36 0.34 0.36
Working Capital Turnover Ratio
3.33 2.66 1.87 2.11 1.75
Cash Conversion Cycle
235.82 235.82 202.87 5.55 97.50
Days of Sales Outstanding
233.02 233.02 198.44 0.00 89.14
Days of Inventory Outstanding
17.04 17.04 19.01 21.85 24.15
Days of Payables Outstanding
14.23 14.23 14.58 16.30 15.79
Operating Cycle
250.05 250.05 217.46 21.85 113.29
Cash Flow Ratios
Operating Cash Flow Per Share
45.67 32.66 9.73 46.33 24.55
Free Cash Flow Per Share
-0.99 12.98 3.88 26.14 -16.88
CapEx Per Share
46.65 19.68 5.85 20.19 41.44
Free Cash Flow to Operating Cash Flow
-0.02 0.40 0.40 0.56 -0.69
Dividend Paid and CapEx Coverage Ratio
0.64 1.66 1.66 2.30 0.59
Capital Expenditure Coverage Ratio
0.98 1.66 1.66 2.30 0.59
Operating Cash Flow Coverage Ratio
0.90 38.09 16.93 0.00 0.00
Operating Cash Flow to Sales Ratio
0.17 0.13 0.05 0.26 0.17
Free Cash Flow Yield
0.69%0.69%0.15%1.30%-0.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
36.02 61.94 130.13 152.05 322.28
Price-to-Sales (P/S) Ratio
5.19 7.76 12.32 11.41 14.26
Price-to-Book (P/B) Ratio
5.29 7.15 11.21 9.66 15.20
Price-to-Free Cash Flow (P/FCF) Ratio
-1.37K 144.87 647.99 76.78 -122.31
Price-to-Operating Cash Flow Ratio
29.72 57.57 258.55 43.33 84.11
Price-to-Earnings Growth (PEG) Ratio
1.47 1.10 2.80 1.44 -4.16
Price-to-Fair Value
5.29 7.15 11.21 9.66 15.20
Enterprise Value Multiple
16.13 30.76 58.49 54.36 145.06
Enterprise Value
16.43B 16.43B 22.45B 16.82B 17.36B
EV to EBITDA
30.76 30.76 58.49 54.36 145.06
EV to Sales
6.62 6.62 10.74 9.44 12.31
EV to Free Cash Flow
123.54 123.54 564.56 63.53 -105.62
EV to Operating Cash Flow
49.09 49.09 225.26 35.85 72.63
Tangible Book Value Per Share
256.59 258.72 221.93 205.29 134.19
Shareholders’ Equity Per Share
256.59 262.78 224.33 207.73 135.83
Tax and Other Ratios
Effective Tax Rate
0.32 0.30 0.29 0.37 0.32
Revenue Per Share
261.60 242.15 204.10 175.93 144.80
Net Income Per Share
37.67 30.35 19.33 13.20 6.41
Tax Burden
0.70 0.70 0.71 0.63 0.68
Interest Burden
1.07 1.07 0.94 1.00 1.05
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.38 0.38 0.40 0.39 0.47
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.08 1.08 0.36 2.21 2.61
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis